Fig. 3From: Efficacy and immunogenicity of insulin biosimilar compared to their reference products: a systematic review and meta-analysisChange all mean of 7 points- or 8 points- self-monitoring of blood glucose (mmol/L) at 24–52 weeksBack to article page